ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,509, issued on July 29, was assigned to Multitude Inc. (Shanghai).

"Antibodies specific to MUC18" was invented by Bing Hou (Shanghai), Peng Chen (Shanghai), Junli Liu (Shanghai), Shu-Hui Liu (Redwood City, Calif.) and Xun Meng (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies specific to MUC18 (a.k.a. MCAM or CD146) and uses thereof for therapeutic and diagnostic purposes are provided. Also provided herein are chimeric antigen receptors (CARs) comprising an extracellular antigen-binding fragment that binds MUC18 and immune cells expressing such."

The patent was filed on June 17, 2021, under Application No. 17/350,995.

*For furthe...